ABBVIE SUBMITS BIOLOGICS LICENSE APPLICATION (BLA) FOR ETENTAMIG TO U.S. FDA FOR ADULTS LIVING WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Reuters · 2d ago

Please log in to view news